Related Experiment Videos
Mollaret's meningitis responding to phenylbutazonum. A case report
Clinical Neurology and Neurosurgery
|January 1, 1985
Summary
This case study presents a patient with Mollaret's meningitis, a recurrent aseptic meningitis. The patient showed a positive response to phenylbutazone, a novel therapeutic approach for this condition.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Mollaret's meningitis is a form of recurrent aseptic meningitis characterized by episodes of cerebrospinal fluid pleocytosis.
- Diagnostic criteria for Mollaret's meningitis can be challenging due to its episodic nature and varied presentations.
- Previous therapeutic strategies for recurrent Mollaret's meningitis have yielded variable success rates.
Observation:
- A patient presented with clinical and laboratory features consistent with Mollaret's meningitis.
- The patient's meningitis exhibited unusual characteristics, prompting a review of diagnostic criteria.
- The recurrent nature of the aseptic meningitis was a prominent feature of the case.
Findings:
- The patient experienced a significant clinical improvement following treatment with phenylbutazone.
- This marks the first reported instance of phenylbutazone effectively managing Mollaret's meningitis.
- The response suggests phenylbutazone may be a viable therapeutic option for specific cases.
Implications:
- This case highlights the potential utility of phenylbutazone in managing recurrent aseptic meningitis.
- Further research is warranted to explore the efficacy and safety of phenylbutazone in Mollaret's meningitis.
- Understanding unusual presentations can refine diagnostic approaches and treatment strategies for aseptic meningitis.